Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2,527,521,347
-
Number of holders
-
3,501
-
Total 13F shares, excl. options
-
1,941,852,214
-
Shares change
-
+13,091,012
-
Total reported value, excl. options
-
$256,040,362,493
-
Value change
-
+$1,890,608,443
-
Put/Call ratio
-
85%
-
Number of buys
-
1,597
-
Number of sells
-
-1,585
-
Price
-
$131.95
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q1 2024
3,715 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q1 2024.
Merck & Co., Inc. - Common Stock (MRK) has 3,501 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,941,852,214 shares
of 2,527,521,347 outstanding shares and own 77% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (243,269,899 shares), BlackRock Inc. (207,015,477 shares), STATE STREET CORP (117,425,530 shares), WELLINGTON MANAGEMENT GROUP LLP (86,348,259 shares), GEODE CAPITAL MANAGEMENT, LLC (56,411,229 shares), FMR LLC (52,170,919 shares), MORGAN STANLEY (41,505,855 shares), BANK OF AMERICA CORP /DE/ (36,011,954 shares), NORGES BANK (29,933,953 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (29,639,517 shares).
This table shows the top 3,501 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.